Information Journal Paper
APA:
Copy. (2020). Acetazolamide, nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19). CUREUS, 12(3), 0-0. SID. https://sid.ir/paper/766298/en
Vancouver:
Copy. Acetazolamide, nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19). CUREUS[Internet]. 2020;12(3):0-0. Available from: https://sid.ir/paper/766298/en
IEEE:
Copy, “Acetazolamide, nifedipine and phosphodiesterase inhibitors: rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19),” CUREUS, vol. 12, no. 3, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/766298/en